Opportunities and challenges associated with the launch of nirmatrelvir/ritonavir (Paxlovid) in British Columbia during the COVID-19 pandemic: A qualitative study to explore community pharmacists’ perspectives
Lessons learned from the nirmatrelvir/ritonavir service included a slower approach to program initiation with additional training opportunities and more streamlined prescription options. Pharmacists also wished for better communication support and involvement in the planning of future initiatives.
Authors
- Fawziah Marra
- Brenton M. Wong (ORCID: https://orcid.org/0000-0003-2585-7484)
- Karen Dahri (ORCID: https://orcid.org/0000-0001-5653-6056)
- I fan Kuo (ORCID: https://orcid.org/0000-0002-2660-2777)
- Kerry Wilbur (ORCID: https://orcid.org/0000-0002-5936-4429)
- Jolanta Piszczek
- K.B. Sinclair
Institutions
- Ministry of Health (CA)
- University of British Columbia (CA)
- Government of Canada (CA)
- Vancouver General Hospital (CA)
Publication Details
- Journal
- Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1177/17151635241288577
- Citations
- 1
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.34